We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back toYou-ve-Got-Data-now-what

DIA 2018 Global Annual Meeting

The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe.


You've Got Data #now what?

    Session Chair(s)
      Karla  Childers, MS

      Karla Childers, MS

      • Senior Director, Strategic Projects, Office of the Chief Medical Officer
      • Johnson & Johnson, United States
    The availability of clinical study results can have an immediate impact on a development program. Once these results are available, teams often need to react quickly. To enable swift execution, the team should think in advance about potential outcomes and create a plan prior to the availability of the results that considers the potential outcomes and those who will be impacted. In this session, we will use a case study to demonstrate the importance of planning and also help the audience develop a rubric for thinking through the various elements of a communication plan, including identifying key stakeholders and how to “right size” one’s plan depending on the nature of the event. We will also cover foundational concepts, such as materiality and blinding/unblinding, and how the development phase of a product can influence the impact of the results.
    Learning Objective : Understand the potential implications of key clinical study results, ascertain potential outcomes, identify key stakeholders and formulate project plans, including a communication plan, to execute on the different scenarios
    Speaker(s)
      Diane Rintzler Yen, PhD, PMP

      Planning in Anticipation of the Availability of Key Clinical Study Results

      Diane Rintzler Yen, PhD, PMP

      • Director, Project Management
      • Merck Research Laboratories, United States
      Danielle  Neveles

      To be determined

      Danielle Neveles

      • Global Communications Manager, Lilly Immunology
      • Eli Lilly and Company, United States